OBJECTIVE: Does operating room temperature at cesarean impact neonatal hypothermia and morbidity and mortality as assessed across gestational age? STUDY DESIGN: In this single-center study, cluster randomization of operating room temperature was assigned on a weekly basis. All women undergoing cesarean with delivery of a liveborn infant without major malformations were included. The standard arm was based on the institutional preexisting standard for the operating rooms of 67 F and the treatment arm was 75 F. Neonatal hypothermia was defined as core body temperature on arrival to the admitting nursery of <97.7
OBJECTIVE: Does operating room temperature at cesarean impact neonatal hypothermia and morbidity and mortality as assessed across gestational age? STUDY DESIGN: In this single-center study, cluster randomization of operating room temperature was assigned on a weekly basis. All women undergoing cesarean with delivery of a liveborn infant without major malformations were included. The standard arm was based on the institutional preexisting standard for the operating rooms of 67 F and the treatment arm was 75 F. Neonatal hypothermia was defined as core body temperature on arrival to the admitting nursery of <97.7
F per World Health Organization criteria. The primary study outcome was a composite neonatal morbidity and mortality including need for respiratory support within the first day of life (defined as continuous positive airway pressure or ventilator use), sepsis, hypoglycemia, and neonatal mortality. A planned secondary analysis of preterm infants (<37 weeks) was also performed. RESULTS: From November 2016 to May 2018, 5221 women delivered with 2817 in the 67 F standard management group and 2404 in the 75 F study group. There were no differences in maternal demographics. The rate of neonatal composite morbidity and mortality was not different between the standard and treatment group: 398 (14%) vs 378 (16%), P¼0.106. This was despite a substantial decrease in neonatal hypothermia (<97.7 F) on arrival to the admitting nursery in the treatment group 414 (18%) compared to the standard group 1195 (43%), P¼<0.001. There was also no difference in the composite outcome for preterm infants <37 weeks between the standard and treatment group: 194 (49%) vs 185 (54%) respectively; P¼0.248, despite similar findings for rates of hypothermia. Of note, a survey of providers attending deliveries revealed that 81% experienced physical discomfort in the operating room during the study period. CONCLUSION: An 8 degree Fahrenheit increase in operating room temperature significantly reduced the rate of neonatal hypothermia. This decrease was not associated with significant improvement in neonatal morbidity. This increase in operating room temperature was met with discomfort from both obstetric and pediatric providers. Preterm infants, who are most likely to experience complications associated with hypothermia did not show improvement in the composite outcome with an increase in operating room temperature.
OBJECTIVE:
To compare interpretability of two intrapartum abdominal fetal heart rate (FHR) monitoring strategies. We hypothesized that an external fetal electrocardiogram (fECG) monitoring system, a new technology using cable-free abdominal pads, would produce more interpretable FHR data compared to standard of care (SOC) external Doppler FHR monitoring. STUDY DESIGN: Randomized trial conducted at 4 Utah hospitals. Patients were enrolled at labor admission and randomized in blocks based on body mass index (BMI) to SOC or fECG. Primary outcome was the percentage of interpretable minutes of FHR tracing. An interpretable minute was defined as >25% FHR data present and no more than 25% continuous missing FHR data or artifact present. FHR tracings were read in blinded fashion by two reviewers. We also considered the rate of successful device set up, defined as the ability to obtain any interpretable FHR tracing, as well as the number of interpretable 10 minute FHR segments, device adjustments, clinical outcomes, and patient/provider device satisfaction as determined by Likert scale survey. We calculated that 100 patients per arm (200 total) would be needed to detect a 5% difference in interpretability with 95% power. RESULTS: 218 women were randomized, 108 to fECG and 110 to SOC (Figure) . Device set up failure occurred more often in the fECG group (7.4% vs 0% for SOC). There were no differences in the primary outcome or 10 minute FHR segment analyses, but fECG produced more interpretable FHR tracing in BMI30 (Table) . Maternal demographics and clinical outcomes were similar between arms. More device changes occurred in the fECG group, however fECG use required fewer nursing adjustments compared to SOC. There was no difference in physician device satisfaction between groups, but fECG generated higher patient device satisfaction scores. CONCLUSION: Although the primary outcome did not differ between groups, patients preferred the fECG system. Significant differences were noted with BMI stratification, where fECG outperformed SOC in women with BMI30. To our knowledge, this is the first randomized clinical comparison of an external fECG device and SOC. Further investigation should focus on predictors of fECG device failure and determining settings in which fECG may be the preferred and more cost-effective FHR monitoring strategy.
Oral Concurrent 4 OB QUALITY AND SAFETY ajog.org OBJECTIVE: To determine the effect of an order-set change incorporating standing acetaminophen and nonsteroidal anti-inflammatory drug (NSAID) use on oral opioid consumption post-cesarean delivery across a multi-hospital system. STUDY DESIGN: We implemented a quality improvement intervention across a network of six hospitals comprised of two large tertiary care centers, two mid-sized community hospitals, and two small community hospitals. The network-wide electronic post-cesarean delivery order set was changed to alter the timing of acetaminophen and NSAID orders from as-needed to standing, and to optimize the dosage of these medications. As-needed opioid orders remained the same before and after the intervention. Using generalized linear regression models, we assessed the impact of this intervention on the average milligrams of morphine equivalent (MME) of oral opioids consumed per patient during the 8 months prior to the intervention and the 8 months following the intervention.
RESULTS:
We evaluated a total of 4666 women delivered via cesarean at 6 network hospitals. The two large tertiary care centers delivering a total of 1808 and 1254 patients, respectively, demonstrated a significant decrease in mean oral opioid consumption before and after the intervention (118.0 to 81.6 MME p<0.001, and 186.4 to 136.3 MME p¼0.01). The four community hospitals delivering a total of 997, 480, 29 and 27 patients, respectively, showed no significant change in mean oral opioid consumption before and after the intervention (93.1 to 86.3 MME, p¼0.66, 210.3 to 218.5 MME p¼0.72, 55.5 to 63.1 MME p¼0.77, and 50.0 to 23.7 MME p¼0.06). There was a trend towards less opioid use post-intervention in the smallest community hospital. CONCLUSION: Order sets incorporating standing acetaminophen and NSAID use after cesarean is associated with decreased oral opioid consumption post-operatively in some settings. Our intervention was associated with the greatest impact in tertiary care centers where multiple initiatives have heightened awareness of the risks associated with opioid use.
54 Does a surgical site infection reduction bundle reduce racial disparities in infection after cesarean delivery?
Tetsuya Kawakita
MedStar Washington Hospital Center, Washington, DC OBJECTIVE: Previous studies have shown that black women are more likely to have surgical site infections after cesarean delivery compared with non-black women. We sought to examine the effect of a
